It was reported yesterday that International Isotopes Incorporated (OTCQB: INIS), a company focused on radioisotopes and radiochemicals, has named Dr Robert W Atcher, PhD, MBA, FSNMMI as its new director.
Dr Atcher recently retired from Los Alamos National Laboratory where he worked on various medical applications for isotopes. He presently serves as the President of the Education and Research Foundation for the Society of Nuclear Medicine and Molecular Imaging and is a past president and fellow of the Society of Nuclear Medicine and Molecular Imaging.
Steve Laflin, Chief Executive Officer of the Company, said, 'The Company is very pleased to have Dr Atcher on its Board of Directors. Dr Atcher has a wealth of experience in the industry and his participation on the Board will provide INIS with valuable experience and advice on new products the Company plans to pursue.'
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer